Diabetic Foot Ulcer - Drug Pipeline Landscape, 2022

Global Insight Services have recently published a report on Diabetic Foot Ulcer - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.

A diabetic foot ulcer is an open sore or wound that occurs in patients with diabetes and is commonly located on the bottom of the foot. It is one of the health complications caused due to uncontrolled diabetes, people with diabetes may also suffer from lower extremity arterial disease, which is a condition that leads to reduced blood flow. These problems make the feet vulnerable to skin sores, also known as ulcers. They usually occur under the big toes and surrounding areas.

Read more about Diabetic Foot Ulcer - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/diabetic-foot-ulcer-drug-pipeline-landscape-2022

Diabetic foot ulcers are mostly caused by poor blood circulation, hyperglycaemia, and nerve damage. Nerve damage reduces sensitivity to foot pain and results in painless wounds that can cause ulcers.

Diabetic foot ulcers are of two types, neuropathic ulcers, and vascular ulcers. The most visible sign of a serious foot ulcer is black tissue (called eschar) surrounding the ulcer. This forms because of an absence of healthy blood flow to the area around the ulcer.

Report Highlights

Global Insight Service's, Diabetic Foot Ulcer - Drug Pipeline Landscape, 2022 report provides an overview of the Diabetic Foot Ulcer pipeline drugs. This report covers detailed insights on Diabetic Foot Ulcer drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Diabetic Foot Ulcer pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31064

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

Some of the key players involved in development of Diabetic Foot Ulcer therapeutics are :

• Alan Laboratories Inc
• Anterogen Co., Ltd.
• Aposcience AG
• APstem Therapeutics
• Aurealis Oy
• Biofilm Pharma
• Blue Blood Biotech Corp.
• Cellics Therapeutics Inc
• Cellresearch Corp Pte Ltd
• Charsire Biotechnology Corp
• CSA Biotechnologies LLC
• Cynata Therapeutics Limited
• Destiny Pharma Plc
• Energenesis Biomedical Co., Ltd
• Helixmith Co., Ltd.
• Lakewood-Amedex Inc
• MediWound Ltd
• Microbion Corporation

Buy this report: https://www.globalinsightservices.com/checkout/single_user/GIS31064

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.